Laurus Labs Ltd.

₹1379.7

- 9.60 (-0.69%)

02:23 pm - close price

BSE: LAURUSLABS

NSE: LAURUSLABS

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 16.46Good: 5

✅

Adjusted EPS

Bad: 3Current: 16.46Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 18.20Good: 20

🟡

Current Ratio

Bad: 1Current: 1.33Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 18.31Good: 15

✅

Debt to Total Assets

Bad: 1Current: 22.81Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 16.46Good: 5

✅

Adjusted EPS

Bad: 3Current: 16.46Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 18.20Good: 20

🟡

Current Ratio

Bad: 1Current: 1.33Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 18.31Good: 15

✅

Debt to Total Assets

Bad: 1Current: 22.81Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	1181.79	1224.45	1194.92	1439.67	1194.91
Expenditure+	1015.07	1036.58	1013.50	1198.18	1023.71
Other Income+	3.60	1.78	2.43	18.53	2.51
Operating Profit	166.72	187.87	181.42	241.49	171.20
Interest	39.19	42.39	50.82	50.50	49.19
Depreciation and Amortization	90.55	93.37	98.41	102.25	106.06
Profit Before Tax	38.97	51.69	32.79	106.97	18.93
Tax+	12.18	14.57	9.45	31.95	6.25
Net Profit	26.79	37.12	23.34	75.02	12.68

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	4935.57	6040.55	5040.83	5553.96	6812.90
Operational Expenses+	3513.14	4448.36	4263.33	4498.68	5035.19
Operating Profit	1422.43	1592.19	777.50	1055.28	1777.71
Other Income	15.30	6.00	26.34	75.10	54.95
OPM %	28.82	26.36	15.42	19.00	26.09
Depreciation and Amortisation	251.49	324.08	384.58	430.09	480.05
Interest	102.39	165.17	182.90	216.00	170.73
Profit Before Tax	1083.85	1108.94	236.36	484.29	1181.88
Tax	200.70	281.59	68.01	129.22	292.03
Net Profit	827.52	784.53	157.68	358.32	888.79

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	6968.04	7660.40	8387.03	9335.57	10511.19
Liabilities+	6968.04	7660.40	8387.03	9335.57	10511.19

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	911.10	993.90	665.69	601.65	1623.50
Cash from Investing Activity	-914.34	-996.06	-822.42	-681.72	-1088.66
Cash from Financing Activity	30.26	-26.64	249.83	39.28	-524.72
Net Cash Flow	27.02	-28.80	93.10	-40.79	10.12
Opening Cash & Cash Equivalents	48.46	75.35	45.67	138.94	99.54
Closing Cash & Cash Equivalents	75.35	45.67	138.94	99.54	112.66

Shareholder Pattern

In %	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23
Promoters+	27.49	27.49	27.59	27.59	27.62	27.62	27.18	27.18	27.19	27.19
Public+	72.51	72.51	72.41	72.41	72.38	72.38	72.82	72.82	72.81	72.81
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	292281	280756	283678	280223	292905	292214	309063	324059	356830	382880

Corporate Actions

185 events in the last 3 years

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	911.10	993.90	665.69	601.65	1623.50
Cash from Investing Activity	-914.34	-996.06	-822.42	-681.72	-1088.66
Cash from Financing Activity	30.26	-26.64	249.83	39.28	-524.72
Net Cash Flow	27.02	-28.80	93.10	-40.79	10.12
Opening Cash & Cash Equivalents	48.46	75.35	45.67	138.94	99.54
Closing Cash & Cash Equivalents	75.35	45.67	138.94	99.54	112.66

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	4935.57	6040.55	5040.83	5553.96	6812.90
Operational Expenses+	3513.14	4448.36	4263.33	4498.68	5035.19
Operating Profit	1422.43	1592.19	777.50	1055.28	1777.71
Other Income	15.30	6.00	26.34	75.10	54.95
OPM %	28.82	26.36	15.42	19.00	26.09
Depreciation and Amortisation	251.49	324.08	384.58	430.09	480.05
Interest	102.39	165.17	182.90	216.00	170.73
Profit Before Tax	1083.85	1108.94	236.36	484.29	1181.88
Tax	200.70	281.59	68.01	129.22	292.03
Net Profit	827.52	784.53	157.68	358.32	888.79

Ratios

Reported EPS

Bad: 2Current: 16.46Good: 5

✅

Adjusted EPS

Bad: 3Current: 16.46Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 18.20Good: 20

🟡

Current Ratio

Bad: 1Current: 1.33Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 18.31Good: 15

✅

Debt to Total Assets

Bad: 1Current: 22.81Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 16.46Good: 5

✅

Adjusted EPS

Bad: 3Current: 16.46Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 18.20Good: 20

🟡

Current Ratio

Bad: 1Current: 1.33Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 18.31Good: 15

✅

Debt to Total Assets

Bad: 1Current: 22.81Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	6968.04	7660.40	8387.03	9335.57	10511.19
Liabilities+	6968.04	7660.40	8387.03	9335.57	10511.19

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	1181.79	1224.45	1194.92	1439.67	1194.91
Expenditure+	1015.07	1036.58	1013.50	1198.18	1023.71
Other Income+	3.60	1.78	2.43	18.53	2.51
Operating Profit	166.72	187.87	181.42	241.49	171.20
Interest	39.19	42.39	50.82	50.50	49.19
Depreciation and Amortization	90.55	93.37	98.41	102.25	106.06
Profit Before Tax	38.97	51.69	32.79	106.97	18.93
Tax+	12.18	14.57	9.45	31.95	6.25
Net Profit	26.79	37.12	23.34	75.02	12.68

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Shareholder Pattern

In %	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23
Promoters+	27.49	27.49	27.59	27.59	27.62	27.62	27.18	27.18	27.19	27.19
Public+	72.51	72.51	72.41	72.41	72.38	72.38	72.82	72.82	72.81	72.81
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	292281	280756	283678	280223	292905	292214	309063	324059	356830	382880

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Laurus Labs Ltd.

₹1379.7

- 9.60 (-0.69%)

02:23 pm - close price

BSE: LAURUSLABS

NSE: LAURUSLABS

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Corporate Actions

185 events in the last 3 years